Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (2)

Search Parameters:
Keywords = laser soft tissue dissection

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 7775 KiB  
Article
Application of Thulium Fiber Laser in Plastic Surgery
by Anastasiya S. Borisenko, Valentin I. Sharobaro, Alexey E. Avdeev, Yousif M. Ahmed Alsheikh, Anna S. Bairamova, Olga A. Gafurova and Vera A. Smolyannikova
Cosmetics 2025, 12(2), 39; https://doi.org/10.3390/cosmetics12020039 - 28 Feb 2025
Viewed by 1284
Abstract
We present our experience of using the UROLASE+ surgical system, based on thulium laser technology, in the context of plastic surgery. Our work with the thulium fiber laser for soft tissue dissection in vitro, ex vivo, and in vivo is described, and the [...] Read more.
We present our experience of using the UROLASE+ surgical system, based on thulium laser technology, in the context of plastic surgery. Our work with the thulium fiber laser for soft tissue dissection in vitro, ex vivo, and in vivo is described, and the positive outcomes of using the thulium fiber laser, which has not previously been employed in aesthetic surgery of the face and body, are demonstrated in this study. Integration of the thulium fiber laser may enhance safety and facilitate tissue dissection through more precise interventions, reduced blood loss, and improved clinical outcomes. This is particularly relevant for patients who have undergone cosmetic procedures leading to fibrotic changes in soft tissues, which complicate inter-tissue dissection when using traditional methods. Full article
(This article belongs to the Section Cosmetic Technology)
Show Figures

Figure 1

18 pages, 5770 KiB  
Article
Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
by Shashwat Sharad, Zsófia M. Sztupinszki, Yongmei Chen, Claire Kuo, Lakshmi Ravindranath, Zoltan Szallasi, Gyorgy Petrovics, Taduru L. Sreenath, Albert Dobi, Inger L. Rosner, Alagarsamy Srinivasan, Shiv Srivastava, Jennifer Cullen and Hua Li
Cancers 2019, 11(12), 1995; https://doi.org/10.3390/cancers11121995 - 12 Dec 2019
Cited by 15 | Viewed by 4053
Abstract
Dysfunctions of androgen/TGF-β signaling play important roles in prostate tumorigenesis. Prostate Transmembrane Protein Androgen Induced 1 (PMEPA1) inhibits androgen and TGF-β signaling via a negative feedback loop. The loss of PMEPA1 confers resistance to androgen signaling inhibitors and promotes bone metastasis. [...] Read more.
Dysfunctions of androgen/TGF-β signaling play important roles in prostate tumorigenesis. Prostate Transmembrane Protein Androgen Induced 1 (PMEPA1) inhibits androgen and TGF-β signaling via a negative feedback loop. The loss of PMEPA1 confers resistance to androgen signaling inhibitors and promotes bone metastasis. Conflicting reports on the expression and biological functions of PMEPA1 in prostate and other cancers propelled us to investigate isoform specific functions in prostate cancer (PCa). One hundred and twenty laser capture micro-dissection matched normal prostate and prostate tumor tissues were analyzed for correlations between quantitative expression of PMEPA1 isoforms and clinical outcomes with Q-RT-PCR, and further validated with a The Cancer Genome Atlas (TCGA) RNA-Seq dataset of 499 PCa. Cell proliferation was assessed with cell counting, plating efficiency and soft agar assay in androgen responsive LNCaP and TGF-β responsive PC3 cells. TGF-β signaling was measured by SMAD dual-luciferase reporter assay. Higher PMEPA1-a mRNA levels indicated biochemical recurrence (p = 0.0183) and lower PMEPA1-b expression associated with metastasis (p = 0.0173). Further, lower PMEPA1-b and a higher ratio of PMEPA1-a vs. -b were correlated to higher Gleason scores and lower progression free survival rate (p < 0.01). TGF-β-responsive PMEPA1-a promoted PCa cell growth, and androgen-responsive PMEPA1-b inhibited cancer cell proliferation. PMEPA1 isoforms -a and -b were shown to be promising candidate biomarkers indicating PCa aggressiveness including earlier biochemical relapse and lower disease specific life expectancy via interrupting androgen/TGF-β signaling. Full article
(This article belongs to the Special Issue Prostate Cancer: Past, Present, and Future)
Show Figures

Graphical abstract

Back to TopTop